Proteoglycan gene expression is decreased in abdominal aortic aneurysms

Area of Science:

• Vascular biology and extracellular matrix (ECM) research.
• Molecular mechanisms underlying aortic aneurysm development.

Background:

• Abdominal aortic aneurysms (AAA) involve altered ECM protein biosynthesis and increased proteolysis.
• Small proteoglycans, biglycan and decorin, are key ECM components regulating cell proliferation and collagen assembly.

Purpose of the Study:

• To quantify mRNA levels of biglycan and decorin in normal aorta (NA) versus AAA.
• Investigate the role of biglycan and decorin in AAA pathogenesis.

Main Methods:

• Utilized Northern blot hybridization and competitive polymerase chain reaction (PCR) for mRNA quantification.
• RNA was isolated from both normal aorta and AAA tissues.
• Data normalized to glyceraldehyde-3-phosphate dehydrogenase or ribosomal RNA and analyzed using unpaired t-tests.

Main Results:

• Observed a statistically significant 15-fold decrease in biglycan mRNA expression in AAA compared to NA (176.9% vs 11.8%, P < 0.001).
• Decorin mRNA expression remained unchanged in AAA tissues relative to normal aorta.

Conclusions:

• The substantial decrease in biglycan mRNA is specific to aneurysmal aortic disease.
• This downregulation contrasts with increased biglycan expression in atherosclerosis and restenosis.
• Reduced biglycan gene expression and biosynthesis may significantly alter aortic physiology and ECM architecture in AAA.